Proteomics

Dataset Information

0

Novel Proteome Extraction Method Illustrate a Conserved Immunological Signature of MSI-H Colorectal Tumors


ABSTRACT: Utilizing the novel TOP clinical proteome extraction to better understand the immune phenotype of MSI-H CRC tumors

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Colon

DISEASE(S): Colon Cancer

SUBMITTER: Gilad Vainer  

LAB HEAD: Gilad Vainer

PROVIDER: PXD017821 | Pride | 2020-07-10

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
OxidationMSites.txt Txt
QEP2_GVAI_2_00750_1_230316.raw Raw
QEP2_GVAI_2_00750_2_230316.raw Raw
QEP2_GVAI_2_01563_10_1_230316.raw Raw
QEP2_GVAI_2_02301_4_1_230316.raw Raw
Items per page:
1 - 5 of 27
altmetric image

Publications

Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.

Vainer Elez D ED   Kania-Almog Juliane J   Zatara Ghadeer G   Levin Yishai Y   Vainer Gilad W GW  

Molecular & cellular proteomics : MCP 20200708 10


Using a simple, environment friendly proteome extraction (TOP), we were able to optimize the analysis of clinical samples. Using our TOP method we analyzed a clinical cohort of microsatellite stable (MSS) and unstable (MSI-H) colorectal carcinoma (CRC). We identified a tumor cell specific, STAT1-centered, immune signature expressed by the MSI-H tumor cells. We then showed that long, but not short, exposure to Interferon-γ induces a similar signature <i>in vitro</i> We identified 10 different tem  ...[more]

Similar Datasets

2020-07-10 | PXD019254 | Pride
2020-07-10 | PXD019252 | Pride
2021-09-09 | PXD023344 | Pride
2021-09-09 | PXD023345 | Pride
2022-02-17 | PXD025968 | Pride
2020-05-26 | PXD015247 | Pride
2022-09-06 | PXD025224 | Pride
2024-02-12 | PXD002526 | Pride
2021-09-09 | PXD020585 | Pride
2018-12-20 | PXD011367 | Pride